Protective effect of glucagon-like peptide-1 agents on reperfusion injury for acute myocardial infarction: a meta-analysis of randomized controlled trials

Reperfusion Injury ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon-like peptide-1 mimetics, optimal for Asian type 2 diabetes patients with and without overweight/obesity: meta-analysis of randomized controlled trials

Scientific Reports ◽

10.1038/s41598-017-16018-9 ◽

2017 ◽

Vol 7 (1) ◽

Cited By ~ 4

Author(s):

Fang Zhang ◽

Lizhi Tang ◽

Yuwei Zhang ◽

Qingguo Lü ◽

Nanwei Tong

Keyword(s):

Type 2 Diabetes ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Glucagon Like Peptide 1 ◽

Diabetes Patients

Impact of glucagon‐like peptide‐1 receptor agonists on adiponectin concentrations: a meta‐analysis of randomized controlled trials

British Journal of Clinical Pharmacology ◽

10.1111/bcp.14855 ◽

2021 ◽

Author(s):

Luis E. Simental‐Mendía ◽

Adriana Sánchez‐García ◽

Enrique Linden‐Torres ◽

Mario Simental‐Mendía

Keyword(s):

Meta Analysis ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Systematic review/Meta-analysis Clinical outcomes of second- versus first-generation drug-eluting stents in patients with acute myocardial infarction: a meta-analysis of randomized controlled trials

Archives of Medical Science ◽

10.5114/aoms.2014.44855 ◽

2014 ◽

Vol 4 ◽

pp. 643-650 ◽

Cited By ~ 3

Author(s):

Guodong Wu ◽

Guoqiang Sun ◽

Ruihong Zhao ◽

Mingli Sun

Keyword(s):

Myocardial Infarction ◽

Systematic Review ◽

Acute Myocardial Infarction ◽

First Generation ◽

Meta Analysis ◽

Drug Eluting Stents ◽

Controlled Trials ◽

Randomized Controlled ◽

Drug Eluting

Effects of timing on intracoronary autologous bone marrow-derived cell transplantation in acute myocardial infarction: a meta-analysis of randomized controlled trials

Stem Cell Research & Therapy ◽

10.1186/s13287-017-0680-5 ◽

2017 ◽

Vol 8 (1) ◽

Cited By ~ 10

Author(s):

Jia-ying Xu ◽

Dai Liu ◽

Yang Zhong ◽

Rong-chong Huang

Keyword(s):

Myocardial Infarction ◽

Acute Myocardial Infarction ◽

Bone Marrow ◽

Cell Transplantation ◽

Meta Analysis ◽

Autologous Bone Marrow ◽

Controlled Trials ◽

Randomized Controlled ◽

Autologous Bone

The good companions: insulin and glucagon-like peptide-1 receptor agonist in type 2 diabetes. A systematic review and meta-analysis of randomized controlled trials

Diabetes Research and Clinical Practice ◽

10.1016/j.diabres.2019.06.009 ◽

2019 ◽

Vol 154 ◽

pp. 101-115 ◽

Cited By ~ 5

Author(s):

Maria Ida Maiorino ◽

Paolo Chiodini ◽

Giuseppe Bellastella ◽

Lorenzo Scappaticcio ◽

Miriam Longo ◽

...

Keyword(s):

Systematic Review ◽

Type 2 Diabetes ◽

Receptor Agonist ◽

Meta Analysis ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Author response for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v3/response1 ◽

2019 ◽

Author(s):

Edoardo Mannucci ◽

Ilaria Dicembrini ◽

Besmir Nreu ◽

Matteo Monami

Keyword(s):

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Author Response ◽

Controlled Trials ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/review4 ◽

2019 ◽

Keyword(s):

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v2/review2 ◽

2019 ◽

Author(s):

Per Wändell

Keyword(s):

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v1/review5 ◽

2019 ◽

Keyword(s):

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽

Review for "Glucagon‐like peptide‐1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta‐analysis and subgroup analysis of randomized controlled trials"

10.1111/dom.13888/v1/review1 ◽

2019 ◽

Keyword(s):

Subgroup Analysis ◽

Cardiovascular Events ◽

Meta Analysis ◽

Cardiovascular Outcomes ◽

Controlled Trials ◽

Receptor Agonists ◽

Randomized Controlled ◽

Glucagon Like Peptide ◽